Xiaoming Jia

ORCID: 0000-0001-7949-6173
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lipoproteins and Cardiovascular Health
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Heart Failure Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiovascular Health and Risk Factors
  • Lipid metabolism and disorders
  • Smoking Behavior and Cessation
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Function and Risk Factors
  • Fatty Acid Research and Health
  • Diabetes Treatment and Management
  • Cardiac pacing and defibrillation studies
  • Cancer, Lipids, and Metabolism
  • Atrial Fibrillation Management and Outcomes
  • Blood Pressure and Hypertension Studies
  • Cardiac Arrhythmias and Treatments
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Coronary Interventions and Diagnostics
  • Eicosanoids and Hypertension Pharmacology
  • Cardiac electrophysiology and arrhythmias
  • Nutritional Studies and Diet
  • Cardiac Valve Diseases and Treatments
  • Pharmaceutical Economics and Policy

Baylor College of Medicine
2017-2025

China Agricultural University
2022

Yale University
2020

Houston Methodist
2020

Methodist Hospital
2020

Cancer Research And Biostatistics
2020

Johns Hopkins Hospital
2020

Michael E. DeBakey VA Medical Center
2020

University of California, San Francisco
2020

Xiaomi (China)
2019

Background: We assessed whether plasma troponin I measured by a high-sensitivity assay (hs-TnI) is associated with incident cardiovascular disease (CVD) and mortality in community-based sample without prior CVD. Methods: ARIC study (Atherosclerosis Risk Communities) participants aged 54 to 74 years baseline CVD were included this (n=8121). Cox proportional hazards models constructed determine associations between hs-TnI coronary heart (CHD; myocardial infarction fatal CHD), ischemic stroke,...

10.1161/circulationaha.118.038772 article EN Circulation 2019-04-29

Abstract Aims Interleukin-6 (IL-6) and interleukin-18 (IL-18), important cytokines implicated in atherosclerosis inflammaging, were assessed for associations with global cardiovascular disease (CVD), atrial fibrillation (AF), death older adults. Methods results Participants from Atherosclerosis Risk Communities study Visit 5 (mean age 75.4 ± 5.1 years) IL-6 IL-18 measurements included (n = 5672). Cox regression models used to assess of coronary heart (CHD), ischaemic stroke, failure (HF)...

10.1093/eurjpc/zwad197 article EN European Journal of Preventive Cardiology 2023-06-08

Importance Most studies, especially in primary prevention patients, have evaluated N-terminal B-type natriuretic peptide (NT-proBNP) at one time point. Evaluation of change NT-proBNP may improve risk stratification for incident cardiovascular events. Objective To assess the association between and heart failure (HF) death. Design, Setting, Participants were recruited from 4 US communities enrolled Atherosclerosis Risk Community (ARIC) study. Individuals who attended ARIC visits 2...

10.1001/jamacardio.2022.5309 article EN JAMA Cardiology 2023-02-08

Sex differences exist in heart failure (HF) phenotypes, but there is limited research on the role of sex hormones HF and its subtypes.

10.1210/clinem/dgaa500 article EN The Journal of Clinical Endocrinology & Metabolism 2020-08-08

Abstract Context Lower dehydroepiandrosterone-sulfate (DHEA-S) levels have been inconsistently associated with coronary heart disease (CHD) and mortality. Data are limited for failure (HF) association between DHEA-S change events. Objective Assess associations low DHEA-S/DHEA-S incident HF hospitalization, CHD, mortality in older adults. Design was measured stored plasma from visits 4 (1996-1998) 5 (2011-2013) of the Atherosclerosis Risk Communities study. Follow-up events: 18 years level;...

10.1210/clinem/dgaa518 article EN The Journal of Clinical Endocrinology & Metabolism 2020-08-12

OBJECTIVE Incorporation of comorbidity burden to inform diabetes management in older adults remains challenging. High-sensitivity cardiac troponins are objective, quantifiable biomarkers that may improve risk monitoring adults. We assessed the associations elevations high-sensitivity troponin I (hs-cTnI) and T (hs-cTnT) with comorbidities improvements mortality stratification. RESEARCH DESIGN AND METHODS used logistic regression examine either (≥85th percentile) among 1,835 participants...

10.2337/dc19-2043 article EN Diabetes Care 2020-03-11

Adequate physical activity is an integral requirement for achieving cardiovascular health. Physical inactivity the fourth leading cause of death worldwide. Hence, it important to identify racial/ethnic groups that are less likely achieve sufficient levels, and address barriers meeting requirements.Cross-sectional data from 2006-2015 National Health Interview Survey (NHIS) were used compare self-reported among different groups: non-Hispanic (NH) Whites, NH Blacks, Asians, Hispanics in United...

10.17161/kjm.vol15.17592 article EN cc-by-nc-nd Kansas Journal of Medicine 2022-08-22

<b><i>Introduction:</i></b> Intravascular ultrasound (IVUS) provides intra-procedural guidance in optimizing percutaneous coronary interventions (PCI) and has been shown to improve clinical outcomes stent implantation. However, current data on the benefit of IVUS during PCI ST-elevation myocardial infarction (STEMI) patients is mixed. We performed meta-analysis pooling available assessing IVUS-guided versus angiography-guided STEMI patients....

10.1159/000537682 article EN Cardiology 2024-01-01
Coming Soon ...